<?xml version="1.0" encoding="UTF-8"?>
<HtmlDoc>
    <meta>
        <prop name="uid">https://www.ncbi.nlm.nih.gov/pubmed/28588489?report=xml&amp;format=text</prop>
        <prop name="date">2017-09-29</prop>
        <prop name="copyright">Converted by Semantic Hub (c) 2016</prop>
        <prop name="version">1.0</prop>
        <prop name="query">(potent AND inhibitor AND cancer) : 2015-2017</prop>
    </meta>
    <BODY>
        <ITEM>
            <ITEM_LINK>https://www.ncbi.nlm.nih.gov/pubmed/28588489?report=xml&amp;format=text</ITEM_LINK>
            <ITEM_BODY>
                <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
                    <PMID Version="1">28588489</PMID>
                    <DateCreated>
                        <Year>2017</Year>
                        <Month>06</Month>
                        <Day>07</Day>
                    </DateCreated>
                    <DateRevised>
                        <Year>2017</Year>
                        <Month>08</Month>
                        <Day>16</Day>
                    </DateRevised>
                    <Article PubModel="Electronic-eCollection">
                        <Journal>
                            <ISSN IssnType="Print">1663-9812</ISSN>
                            <JournalIssue CitedMedium="Print">
                                <Volume>8</Volume>
                                <PubDate>
                                    <Year>2017</Year>
                                </PubDate>
                            </JournalIssue>
                            <Title>Frontiers in pharmacology</Title>
                            <ISOAbbreviation>Front Pharmacol</ISOAbbreviation>
                        </Journal>
                        <ArticleTitle>
                            FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases.
                        </ArticleTitle>
                        <Pagination>
                            <MedlinePgn>285</MedlinePgn>
                        </Pagination>
                        <ELocationID ValidYN="Y" EIdType="doi">10.3389/fphar.2017.00285</ELocationID>
                        <Abstract>
                            <AbstractText>
                                Osteosarcoma (OS) is an aggressive primary bone tumor which exhibits aberrantly activated Wnt signaling. The canonical Wnt signaling cascade has been shown to drive cancer progression and metastasis through the activation of Î²-catenin. Hence, small molecule inhibitors of Wnt targets are being explored as primary or adjuvant chemotherapy. In this study, we have investigated the ability of FH535, an antagonist of Wnt signaling, to inhibit the growth of OS cells. We found that FH535 was cytotoxic in all OS cell lines which were tested (143b, U2OS, SaOS-2, HOS, K7M2) but well tolerated by normal human osteoblast cells. Additionally, we have developed an in vitro model of doxorubicin-resistant OS and found that these cells were highly responsive to FH535 treatment. Our analysis provided evidence that FH535 strongly inhibited markers of canonical Wnt signaling. In addition, our findings demonstrate a reduction in PAR-modification of Axin2 indicating inhibition of the tankyrase 1/2 enzymes. Moreover, we observed inhibition of auto-modification of PARP1 in the presence of FH535, indicating inhibition of PARP1 enzymatic activity. These data provide evidence that FH535 acts through the tankyrase 1/2 enzymes to suppress Wnt signaling and could be explored as a potent chemotherapeutic agent for the control of OS.
                            </AbstractText>
                        </Abstract>
                        <AuthorList CompleteYN="Y">
                            <Author ValidYN="Y">
                                <LastName>Gustafson</LastName>
                                <ForeName>Carl T</ForeName>
                                <Initials>CT</Initials>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Mayo Clinic, RochesterMN, United States.
                                    </Affiliation>
                                </AffiliationInfo>
                            </Author>
                            <Author ValidYN="Y">
                                <LastName>Mamo</LastName>
                                <ForeName>Tewodros</ForeName>
                                <Initials>T</Initials>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Mayo Clinic, RochesterMN, United States.
                                    </Affiliation>
                                </AffiliationInfo>
                            </Author>
                            <Author ValidYN="Y">
                                <LastName>Shogren</LastName>
                                <ForeName>Kristen L</ForeName>
                                <Initials>KL</Initials>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Mayo Clinic, RochesterMN, United States.
                                    </Affiliation>
                                </AffiliationInfo>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Mayo Clinic, RochesterMN, United States.
                                    </Affiliation>
                                </AffiliationInfo>
                            </Author>
                            <Author ValidYN="Y">
                                <LastName>Maran</LastName>
                                <ForeName>Avudaiappan</ForeName>
                                <Initials>A</Initials>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Mayo Clinic, RochesterMN, United States.
                                    </Affiliation>
                                </AffiliationInfo>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Mayo Clinic, RochesterMN, United States.
                                    </Affiliation>
                                </AffiliationInfo>
                            </Author>
                            <Author ValidYN="Y">
                                <LastName>Yaszemski</LastName>
                                <ForeName>Michael J</ForeName>
                                <Initials>MJ</Initials>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Mayo Clinic, RochesterMN, United States.
                                    </Affiliation>
                                </AffiliationInfo>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Mayo Clinic, RochesterMN, United States.
                                    </Affiliation>
                                </AffiliationInfo>
                                <AffiliationInfo>
                                    <Affiliation>
                                        Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Mayo Clinic, RochesterMN, United States.
                                    </Affiliation>
                                </AffiliationInfo>
                            </Author>
                        </AuthorList>
                        <Language>eng</Language>
                        <PublicationTypeList>
                            <PublicationType UI="D016428">Journal Article</PublicationType>
                        </PublicationTypeList>
                        <ArticleDate DateType="Electronic">
                            <Year>2017</Year>
                            <Month>05</Month>
                            <Day>23</Day>
                        </ArticleDate>
                    </Article>
                    <MedlineJournalInfo>
                        <Country>Switzerland</Country>
                        <MedlineTA>Front Pharmacol</MedlineTA>
                        <NlmUniqueID>101548923</NlmUniqueID>
                        <ISSNLinking>1663-9812</ISSNLinking>
                    </MedlineJournalInfo>
                    <CommentsCorrectionsList>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Expert Opin Pharmacother. 2011 Feb;12 (2):285-92</RefSource>
                            <PMID Version="1">21226638</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Oncotarget. 2016 May 10;7(19):28000-12</RefSource>
                            <PMID Version="1">27058905</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Cancer Lett. 2016 Jan 28;370(2):286-95</RefSource>
                            <PMID Version="1">26577806</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Clin Genet. 2009 Sep;76(3):242-55</RefSource>
                            <PMID Version="1">19793053</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>PLoS One. 2013 Aug 19;8(8):e72238</RefSource>
                            <PMID Version="1">23977261</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Oncotarget. 2016 May 10;7(19):28273-85</RefSource>
                            <PMID Version="1">27070088</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Oncotarget. 2015 Jul 10;6(19):17570-83</RefSource>
                            <PMID Version="1">25999350</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>BMC Cancer. 2012 Jul 23;12:303</RefSource>
                            <PMID Version="1">22823957</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Onco Targets Ther. 2015 Jul 06;8:1651-70</RefSource>
                            <PMID Version="1">26185454</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>F1000Res. 2016 Apr 19;5:null</RefSource>
                            <PMID Version="1">27134739</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Nat Commun. 2015 Nov 25;6:8904</RefSource>
                            <PMID Version="1">26603103</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Mol Cancer Ther. 2008 Mar;7(3):521-9</RefSource>
                            <PMID Version="1">18347139</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Bioorg Med Chem Lett. 2009 Jul 15;19(14):3825-7</RefSource>
                            <PMID Version="1">19410457</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Semin Cell Dev Biol. 2016 Oct;58:79-85</RefSource>
                            <PMID Version="1">27058752</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Methods Mol Biol. 2011;780:93-115</RefSource>
                            <PMID Version="1">21870257</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Nat Chem Biol. 2009 Feb;5(2):100-7</RefSource>
                            <PMID Version="1">19125156</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Bone Miner Res. 2012 Oct;27(10 ):2118-29</RefSource>
                            <PMID Version="1">22550000</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Leukemia. 2014 Feb;28(2):373-83</RefSource>
                            <PMID Version="1">23760401</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Science. 1998 Nov 20;282(5393):1484-7</RefSource>
                            <PMID Version="1">9822378</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Mol Med Rep. 2014 Apr;9(4):1289-92</RefSource>
                            <PMID Version="1">24482011</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Cancer. 2009 Nov 15;115(22):5339-48</RefSource>
                            <PMID Version="1">19637348</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Clin Oncol. 2015 Sep 20;33(27):3029-35</RefSource>
                            <PMID Version="1">26304877</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Oncogene. 2016 Sep 8;35(36):4787-97</RefSource>
                            <PMID Version="1">26876203</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Cancer Med. 2014 Feb;3(1):36-46</RefSource>
                            <PMID Version="1">24403055</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Exp Cell Res. 2005 Jun 10;306(2):357-63</RefSource>
                            <PMID Version="1">15925592</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Proc Natl Acad Sci U S A. 1988 Oct;85(19):7187-91</RefSource>
                            <PMID Version="1">2902625</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Mol Biol. 2008 May 23;379(1):136-45</RefSource>
                            <PMID Version="1">18436240</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Oncogene. 2003 Nov 20;22(52):8460-71</RefSource>
                            <PMID Version="1">14627987</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>PLoS One. 2012;7(11):e48670</RefSource>
                            <PMID Version="1">23144924</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>BMC Cancer. 2012 Mar 19;12:93</RefSource>
                            <PMID Version="1">22429849</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>PLoS One. 2014 Jun 18;9(6):e99272</RefSource>
                            <PMID Version="1">24940873</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Oncogene. 2015 Sep 24;34(39):5069-79</RefSource>
                            <PMID Version="1">25579177</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Cold Spring Harb Perspect Biol. 2013 Jan 01;5(1):a007898</RefSource>
                            <PMID Version="1">23169527</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Br J Cancer. 2009 Dec 1;101(11):1909-18</RefSource>
                            <PMID Version="1">19888226</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Oncogene. 2009 Jun 11;28(23):2245-56</RefSource>
                            <PMID Version="1">19421142</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Med Chem. 2013 Apr 11;56(7):3012-23</RefSource>
                            <PMID Version="1">23473363</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Neurochem. 2008 Aug;106(4):1855-65</RefSource>
                            <PMID Version="1">18624906</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Med Chem. 2012 Feb 9;55(3):1360-7</RefSource>
                            <PMID Version="1">22233320</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Ann Oncol. 2010 Oct;21 Suppl 7:vii320-5</RefSource>
                            <PMID Version="1">20943636</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Minerva Chir. 1993 Jan;48(1-2):35-45</RefSource>
                            <PMID Version="1">8464555</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Gene. 2007 Jan 15;386(1-2):131-8</RefSource>
                            <PMID Version="1">17079093</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Lancet Oncol. 2016 Oct;17 (10 ):1396-1408</RefSource>
                            <PMID Version="1">27569442</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Exp Clin Cancer Res. 2001 Dec;20(4):553-9</RefSource>
                            <PMID Version="1">11876551</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Calcif Tissue Int. 1985 Sep;37(5):453-60</RefSource>
                            <PMID Version="1">2998572</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>PLoS One. 2012;7(3):e33740</RefSource>
                            <PMID Version="1">22438990</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Transl Med. 2015 Mar 31;13:104</RefSource>
                            <PMID Version="1">25888911</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>BMC Syst Biol. 2012 May 28;6:50</RefSource>
                            <PMID Version="1">22640921</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Nature. 2009 Oct 1;461(7264):614-20</RefSource>
                            <PMID Version="1">19759537</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Mol Med Rep. 2012 Apr;5(4):1033-6</RefSource>
                            <PMID Version="1">22293903</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>J Clin Oncol. 2015 Jul 10;33(20):2279-87</RefSource>
                            <PMID Version="1">26033801</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Cancer Res. 2014 Mar 1;74(5):1495-505</RefSource>
                            <PMID Version="1">24419084</PMID>
                        </CommentsCorrections>
                        <CommentsCorrections RefType="Cites">
                            <RefSource>Cancer Res. 2012 Aug 15;72(16):4154-64</RefSource>
                            <PMID Version="1">22738915</PMID>
                        </CommentsCorrections>
                    </CommentsCorrectionsList>
                    <KeywordList Owner="NOTNLM">
                        <Keyword MajorTopicYN="N">PARP1</Keyword>
                        <Keyword MajorTopicYN="N">Wnt signaling</Keyword>
                        <Keyword MajorTopicYN="N">osteosarcoma</Keyword>
                        <Keyword MajorTopicYN="N">small molecule chemotherapy</Keyword>
                        <Keyword MajorTopicYN="N">tankyrase inhibitor</Keyword>
                    </KeywordList>
                </MedlineCitation>
                <PubmedData>
                    <History>
                        <PubMedPubDate PubStatus="received">
                            <Year>2017</Year>
                            <Month>03</Month>
                            <Day>27</Day>
                        </PubMedPubDate>
                        <PubMedPubDate PubStatus="accepted">
                            <Year>2017</Year>
                            <Month>05</Month>
                            <Day>05</Day>
                        </PubMedPubDate>
                        <PubMedPubDate PubStatus="entrez">
                            <Year>2017</Year>
                            <Month>6</Month>
                            <Day>8</Day>
                            <Hour>6</Hour>
                            <Minute>0</Minute>
                        </PubMedPubDate>
                        <PubMedPubDate PubStatus="pubmed">
                            <Year>2017</Year>
                            <Month>6</Month>
                            <Day>8</Day>
                            <Hour>6</Hour>
                            <Minute>0</Minute>
                        </PubMedPubDate>
                        <PubMedPubDate PubStatus="medline">
                            <Year>2017</Year>
                            <Month>6</Month>
                            <Day>8</Day>
                            <Hour>6</Hour>
                            <Minute>1</Minute>
                        </PubMedPubDate>
                    </History>
                    <PublicationStatus>epublish</PublicationStatus>
                    <ArticleIdList>
                        <ArticleId IdType="pubmed">28588489</ArticleId>
                        <ArticleId IdType="doi">10.3389/fphar.2017.00285</ArticleId>
                        <ArticleId IdType="pmc">PMC5440578</ArticleId>
                    </ArticleIdList>
                </PubmedData>
            </ITEM_BODY>
        </ITEM>
    </BODY>
</HtmlDoc>